Vaginal Area Filler Treatment | Med Aesthetics Miami
Med Aesthetics Miami offers hyaluronic acid filler treatment for the external vaginal area (mons pubis and labia majora) to address volume loss and skin laxity, primarily related to aging or weight change.
This is a cosmetic, external treatment — not a procedure for internal vaginal tissue or a treatment for menopause symptoms, urinary incontinence, or sexual function. Book a private consultation to discuss candidacy and pricing.
Key Takeaways
- This treatment uses hyaluronic acid dermal filler injected into the mons pubis and labia majora to address external volume loss and skin laxity.
- The specific filler product used is selected by the treating provider based on the patient’s anatomy and goals, and its labeling is reviewed with the patient at consultation.
- This is a cosmetic treatment, not a treatment for urinary incontinence, menopause symptoms, or sexual function.
- As with any dermal filler injection, this treatment carries both common temporary effects and less common but serious risks, discussed in full at consultation.
What Is External Vaginal Area Filler Treatment?
This treatment uses hyaluronic acid dermal filler — the same category of filler used for facial volume restoration — injected into the external genital area, specifically the mons pubis and labia majora, to address volume loss and skin laxity. It is a cosmetic, external treatment.
Two separate regulatory points are worth understanding clearly. First, in 2018 the FDA issued a safety communication warning that the safety and effectiveness of energy-based devices marketed for “vaginal rejuvenation” — to treat conditions like urinary incontinence, menopause symptoms, or sexual dysfunction — has not been established. This treatment is not that: it does not use an energy-based device, and it makes no claim to treat any of those conditions.
Second, FDA guidance on dermal fillers specifically advises reviewing each filler product’s labeling, since approved indications, contraindications, and expected duration vary by product — the FDA’s review of a given filler for one body area doesn’t automatically extend to every other area where it might be used.
Med Aesthetics Miami’s clinical team selects the specific filler product for this treatment based on the patient’s anatomy and goals, and reviews that product’s labeling, approved uses, and expected duration directly with the patient at consultation, before any treatment is scheduled.
Patients with concerns about incontinence, menopausal symptoms, or sexual function should consult a physician, such as a urogynecologist, who can evaluate and treat those conditions directly.
What Does This Treatment Address?
Hyaluronic acid filler in the mons pubis and labia majora area is used to address:
- Volume loss in the external genital area related to aging or weight loss
- Skin laxity or a deflated appearance in this area
- Asymmetry between the labia majora
How Does the Treating Provider Decide If This Treatment Is Right for You?
At consultation, the treating provider distinguishes between cosmetic external volume loss — the concern this treatment addresses — and symptoms that suggest a medical evaluation is needed instead, such as pain, irritation, urinary symptoms, or concerns about internal tissue.
Patients presenting with the latter are referred to an appropriate specialist, such as a gynecologist or urogynecologist, rather than treated with cosmetic filler.
Who Is a Candidate for This Treatment?
Good candidates are generally healthy adults seeking cosmetic improvement in facial volume or skin laxity, with realistic expectations for a temporary cosmetic result.
Candidacy, including any exclusions specific to the filler product used, is confirmed against that product’s exact labeling at consultation — not a generalized set of rules that apply to every hyaluronic acid filler.
Patients with an active infection or inflammation in the treatment area are generally advised to delay treatment until the condition resolves.
Pregnant or breastfeeding patients should discuss this treatment with their treating provider and physician before proceeding — per FDA dermal filler guidance, the safety of dermal fillers during pregnancy and breastfeeding has not been established; this is different from a confirmed risk and still warrants individualized discussion.
Patients taking blood-thinning medications should discuss timing with the treating provider, who determines an appropriate plan under medical guidance — patients should never stop a prescribed medication on their own without direction from the prescribing physician.
A confidential consultation with the clinical team reviews medical history and goals to confirm candidacy before any treatment is scheduled.
What Happens During Treatment?
The treatment area is cleaned, and a topical numbing cream is applied. The treating provider then injects the filler in multiple small injections distributed across the treatment area.
Appointment length varies with the extent of treatment; the treating provider confirms the expected timing at the consultation.
What Is Recovery Like?
Mild swelling, bruising, or tenderness at injection sites is common and generally improves over the days following treatment, though the exact timeline varies by individual and by the specific filler used. Patients are typically advised to avoid strenuous exercise and sexual activity for a period following treatment — the treating provider confirms the specific timeframe as part of the practice’s aftercare instructions.
How Long Do Results Last, and Which Filler Is Used?
Results are temporary, consistent with how hyaluronic acid fillers behave generally.
Duration varies by the specific filler product used, the treatment area, and individual factors — the treating provider selects the appropriate product for each patient and reviews its expected duration at consultation, rather than a single fixed timeframe that applies to every patient. Maintenance treatments are typically needed to sustain results over time.
What Are the Risks?
Common, temporary effects of dermal filler injection include swelling, bruising, redness, and tenderness at the injection site.
Per FDA dermal filler guidance, dermal fillers also carry less common but more serious risks. The most significant is unintentional injection into a blood vessel, which can lead to blocked blood flow and, in rare cases, tissue damage, vision changes, or stroke.
Other recognized filler risks include infection, lumps or nodules under the skin, migration of the filler material away from the treatment site, and allergic reaction.
These risks are documented for dermal filler use generally; the treating provider reviews the specific product’s labeling for any additional considerations relevant to this treatment area.
Frequently Asked Questions
Is this a treatment for internal vaginal tissue?
No. This treatment addresses external volume and skin laxity in the mons pubis and labia majora using hyaluronic acid filler. It is a cosmetic treatment for the external area only.
Does this treatment help with urinary incontinence or menopause symptoms?
No. This is a cosmetic filler treatment, not a treatment for urinary incontinence, menopause symptoms, or sexual function. Patients with these concerns should consult a physician who specializes in evaluating and treating those conditions.
Which filler is used for this treatment?
The treating provider selects the specific hyaluronic acid filler based on the patient’s anatomy and goals and reviews that product’s approved uses and labeling directly with the patient at the consultation, since fillers differ in indications and expected duration.
How long do results last?
Results are temporary and vary by the specific filler product used and individual factors. The treating provider discusses the expected duration of your specific treatment plan at the consultation.
What are the risks of this treatment?
Common effects include temporary swelling, bruising, and tenderness. Less common but more serious risks associated with dermal filler injection generally include infection, lumps under the skin, and — rarely — injection into a blood vessel, which can cause tissue damage or other serious complications.
Who is not a candidate for this treatment?
Patients with an active infection in the treatment area are generally advised to delay treatment. Pregnant or breastfeeding patients should discuss this treatment individually with the treating provider, since filler safety in these populations hasn’t been established either way. A consultation confirms individual candidacy against the specific product’s labeling.
Bottom Line
Med Aesthetics Miami offers hyaluronic acid filler treatment for the external genital area to address cosmetic volume loss and skin laxity, using a filler product selected and reviewed with each patient individually.
As with any dermal filler, it carries both common temporary effects and less common serious risks. Results are temporary and require maintenance.
Schedule a private consultation at Coral Gables, Aventura, or Lauderdale-by-the-Sea to discuss candidacy, the specific product used, and pricing.